期刊文献+

并发心衰对慢性阻塞性肺疾病患者预后的影响 被引量:1

Influence of Complication of Heart Failure on Prognosis of Patients with Chronic Obstructive Pulmonany Disease
下载PDF
导出
摘要 目的探讨并发心衰对慢性阻塞性肺疾病(COPD)患者预后的影响。方法 214例COPD患者根据临床、体征和超声心动图分为心衰组和不伴有心衰组,观察并对比两组的生存预后以及因心血管和/或呼吸疾患住院情况。结果随访期间,36例伴心衰者中30例(83%)因COPD恶化或心衰住院,22例死亡。而不伴心衰的178例中,有110例(0.62%)因COPD恶化或心衰住院接受住院治疗,仅12例死亡,死亡率明显低于伴有心衰的患者。结论并发心衰的COPD患者生存预后较差,因心血管系统和/或呼吸系统疾病住院率较高。应重视并积极治疗伴有心衰的COPD患者,阻止病情的进一步恶化。
出处 《现代诊断与治疗》 CAS 2012年第4期213-214,共2页 Modern Diagnosis and Treatment
  • 相关文献

参考文献5

  • 1Casanova CC,DeTorres C,Aguirre-Jaime JP,et al.Inspiratory-to-totallung capacity ratio predicts mortality in patients with chronic obstructivepulmonary disease[J].Am J Respir Crit Care Med,2005,171:591-597.
  • 2Burge PS,Calverley PM,Jones PW,et al.Randomised,double blind,pla-cebo controlled study of fluticasone propionate in patients with moderateto severe chronic obstructive pulmonary disease:the ISOLDE trial[J].BMJ,2000,320:1297-1303.
  • 3FerrerM,Alonso J,Morera J,et al.Chronic obstructive pulmonary diseasestage and health related quality of life.The Quality of Life of ChronicObstructive Pulmonary Disease Study Group[J].Ann Intern Med,1997,127:1072-1079.
  • 4Friedman M,Serby CW,Menjoge SS,et al.Pharmacoeconomic evaluationof a combination of ipratropium plus albuterol compared with ipratropi-um alone and albuterol alone in COPD[J].Chest,1999,115:635-641.
  • 5Global Initiative on Obstructive Lung Disease.Global strategy for the di-agnosis,management,and prevention of chronic obstructive pulmonarydisease[J].Am J Respir Crit Care Med,2001,163:1256-1276.

同被引文献5

引证文献1

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部